Zai Lab li­cens­es pso­ri­a­sis drug from Crescen­do; Hit­Gen, Li­on raise cash for dis­cov­ery and de­vel­op­ment work in Asia

→ Shang­hai’s Zai Lab has inked an ex­clu­sive li­cens­ing deal with Crescen­do Bi­o­log­ics un­der which Zai Lab will de­vel­op, com­mer­cial­ize, and man­u­fac­ture a top­i­cal an­ti­body …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER